Third dose of Pfizer-BioNTech vaccine, incidence of SARS-CoV-2 infection, hospitalization, death
About The Study: This study of 18,000 residents of long-term care facilities in Israel found that those who had received ...
About The Study: This study of 18,000 residents of long-term care facilities in Israel found that those who had received ...
WASHINGTON, June 28, 2022 – Chinese researchers may have found a new approach to treat cancer by using a plasma ...
Does dose reduction for patients on stable opioid therapy have long-term overdose and mental health risks? Researchers from the UC ...
Philadelphia, May 16, 2022 – Herbal supplements may be natural, but that does not mean they are always safe. A ...
Funding: Medical Research Future Fund, mRNA Victoria, Jack Ma Foundation, IFM Investors, Australian Research Council and National Health and Medical ...
New York, NY (April 6, 2022) — Most immunocompromised people with a blood cancer called multiple myeloma benefited from a ...
A Johns Hopkins Children’s Center-led study in animals suggests that high doses of a widely used antibiotic called rifampin may ...
mRNA vaccines are highly effective in preventing covid-19 associated hospital admissions related to the alpha, delta, and omicron variants. But ...
INDIANAPOLIS -- A nationwide study from the U.S. Centers for Disease Control and Prevention (CDC) is the first to show ...
One dose of an anti-parasite drug was just as effective as two at significantly reducing the spread of scabies, the ...
WHAT: In adults who had previously received a full regimen of any of three COVID-19 vaccines granted Emergency Use Authorization ...
A new study that evaluated the effectiveness of the BNT162b2 (Pfizer-BioNTech) vaccine against the Omicron variant indicates that three doses ...
A case series published in Annals of Internal Medicine finds that a fourth dose of an mRNA-based vaccine produces a ...
The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to ...
Peer-reviewed / Randomised Controlled Trial / People The Ad5-nCoV vaccine, developed in China, is 57.5% effective against symptomatic COVID-19 infection ...
Researchers determined the minimally effective dose (MED) of a clinical candidate gene therapy vector for treating hemophilia A. This pharmacology ...
Whether it’s a dollop on your morning cereal or a simple snack on the go, a daily dose of yoghurt ...
The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines ...
Study finds gradual increase in covid infection risk after second vaccine dose Study finds gradual increase in covid infection risk ...
Getting the first dose of a COVID-19 vaccine resulted in significant improvements in U.S. adults' mental health.Credit: Perez-Arce et al, ...
We bring you the latest science news from best research centers and universities around the world. Check our website.
© 2022 Scienmag- Science Magazine: Latest Science News.
© 2022 Scienmag- Science Magazine: Latest Science News.